Expansion of Intended Use Now Includes Posterior-Lateral and Endoscopic Approaches.
Disc Dynamics, Inc., a leading developer of minimally invasive treatment options for low back pain caused by degenerative disc disease (DDD), announced that the CE Mark received in the European Union for its DASCOR® Disc Arthroplasty System has been expanded to incorporate a posterior-lateral surgical approach, as well as an endoscopic approach.
“DASCOR is the only motion preservation technology that can be delivered through multiple surgical approaches,” said Steven Healy, president and CEO of Disc Dynamics. “Surgeons can now match the preferred surgical technique with the patient’s anatomy.”
The device consists of a two-part curable polyurethane and an expandable polyurethane balloon that is inserted into the disc nucleus space after the desiccated nucleus has been removed. The balloon is then injected with a flowable polymer, which creates a complete, patient-specific implant that conforms to the shape and size of the disc space.
In the U.S., Disc Dynamics is currently completing its IDE feasibility clinical study.
About Disc Dynamics Based in Eden Prairie, Minn., Disc Dynamics, Inc. is an orthopedic spine company founded in 2000 to provide patients and physicians with a minimally invasive surgical alternative for treating degenerative disc disease. The company has developed the DASCOR® Disc Arthroplasty System, a catheter-based, minimally invasive nucleus replacement technology for the treatment of degenerated lumbar discs. The goal of the technology is to relieve pain, restore function and preserve anatomy. For more information, visit the company’s Web site at www.discdyn.com.
Source: Disc Dynamics